These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 808993

  • 1. Inhibition of complement-derived enzymes.
    Fearon DT, Austen KF.
    Ann N Y Acad Sci; 1975 Jun 13; 256():441-50. PubMed ID: 808993
    [No Abstract] [Full Text] [Related]

  • 2. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
    Whaley K, Schur PH, Ruddy S.
    J Clin Invest; 1976 Jun 13; 57(6):1554-63. PubMed ID: 819459
    [Abstract] [Full Text] [Related]

  • 3. Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum.
    Machado AJ, Gazzinelli G, Pellegrino J, Dias de Silva W.
    Exp Parasitol; 1975 Aug 13; 38(1):20-9. PubMed ID: 807484
    [No Abstract] [Full Text] [Related]

  • 4. Correlation between levels of breakdown products of C3, C4, and properdin factor B in synovial fluids from patients with rheumatoid arthritis.
    Perrin LH, Nydegger UE, Zubler RH, Lambert PH, Miescher PA.
    Arthritis Rheum; 1977 Mar 13; 20(2):647-52. PubMed ID: 849359
    [Abstract] [Full Text] [Related]

  • 5. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
    Medicus RG, Götze O, Müller-Eberhard HJ.
    J Exp Med; 1976 Oct 01; 144(4):1076-93. PubMed ID: 978134
    [Abstract] [Full Text] [Related]

  • 6. Activation of complement components C3 and factor B in synovial fluids.
    Hunder GG, McDuffie FC, Mullen BJ.
    J Lab Clin Med; 1977 Jan 01; 89(1):160-71. PubMed ID: 830776
    [Abstract] [Full Text] [Related]

  • 7. Activation of the alternative (properdin) pathway by divalent cations.
    Lew FT, Yukiyama Y, Waks HS, Osler AG.
    J Immunol; 1975 Sep 01; 115(3):884-8. PubMed ID: 807649
    [Abstract] [Full Text] [Related]

  • 8. Altered local metabolism of complement components in rheumatoid arthritis.
    Ruddy S.
    Rheumatology; 1975 Sep 01; 6():17-23. PubMed ID: 1105743
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The alternative pathway of complement activation.
    Götze O, Müller-Eberhard HJ.
    Adv Immunol; 1976 Sep 01; 24():1-35. PubMed ID: 798473
    [No Abstract] [Full Text] [Related]

  • 11. Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.
    Schreiber RD, Götze O, Müller-Eberhard HJ.
    J Exp Med; 1976 Oct 01; 144(4):1062-75. PubMed ID: 62010
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT, Austen KF, Ruddy S.
    Rheumatology; 1975 Oct 01; 6():2-16. PubMed ID: 1105744
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Properdin: initiation of alternative complement pathway.
    Fearon DT, Austen KF.
    Proc Natl Acad Sci U S A; 1975 Aug 01; 72(8):3220-4. PubMed ID: 1059108
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.